News articles about Merge Healthcare (NASDAQ:MRGE) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Merge Healthcare earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned news headlines about the technology company an impact score of 46.5016031934268 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Shares of Merge Healthcare (MRGE) opened at 1.12 on Friday. The company’s 50-day moving average is $7.10 and its 200 day moving average is $5.64. Merge Healthcare has a 1-year low of $2.13 and a 1-year high of $7.13. The stock’s market cap is $347.41 million.
WARNING: This piece of content was reported by Community Financial News and is the property of of Community Financial News. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/08/12/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-merge-healthcare-mrge-stock-price-updated.html.
About Merge Healthcare
Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images. The Company operates through two segments: Merge Healthcare and Merge DNA. The Company’s Merge Healthcare segment markets, sells and implements interoperability, imaging and clinical solutions to healthcare providers.
What are top analysts saying about Merge Healthcare Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Merge Healthcare Inc. and related companies.